On June 13, 2013, the Supreme Court of the United States unanimously held that isolated, naturally occurring DNAs are not patent eligible, but synthetically produced cDNAs are. 35 U.S.C. § 101 provides that processes, machines, manufactures, and compositions of matter are patent eligible subject matter. Judicially created exceptions, however, put limits on patent eligibility where patent claims encompass laws of nature, natural phenomena, and abstract ideas. The Court granted certiorari to consider the sole question of whether human genes are patent eligible under 35 U.S.C § 101.